Li, Z., W. K. Lim, S. P. Mahesh, B. Liu, and R. B. Nussenblatt. 2005. Cutting edge: in vivo blockade of human IL-2 receptor induces expansion of CD56bright regulatory NK cells in patients with active uveitis. J. Immunol. 174: 5187–5191 .
In Results and Discussion, after the first sentence in the last paragraph, the authors wish to add the sentences shown below.
Recently, Bielekova et al. described their findings concerning the induction of CD56bright NK cells by anti-IL2R therapy in multiple sclerosis patients (31). This is consistent with our observations in uveitis patients.
The authors also wish to add the citation shown below to References.
31. Bielekova, B., S. Reichert-Scrivner, M. Cerna, H. McFarland, and R. Martin. 2004. CD56bright NK cells mediate immunomodulatory effects of IL-2R-targeted therapy in multiple sclerosis. J. Neuroimmunology 154: 211 (Abstr. 699).